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Mood disorders, including depression and anxiety, are among the most 
prevalent mental illnesses with high socioeconomic impact. Although the 
underlying mechanisms have not yet been clearly defined in the last decade the 
importance of the role of neuropeptides, including Galanin (GAL), and/or their 
receptors in the treatment of stress-related mood disorders is becoming 
increasingly apparent.   
GAL is involved in mood regulation, including depression-related and anxiety-
like behaviors. Activation of GALR1 and GALR3 receptors results in a 
depression like behavior while stimulation of GALR2 receptor leads to anti-
depressant-like effects. Moreover, GAL modulates 5-HT1A receptors (5-
HT1AR), a key receptor in depression at autoreceptor and postsynaptic level in 
the brain. This interaction can in part be due to the existence of GALR1-5-
HT1AR heteroreceptor complexes in discrete brain regions [1]. Not only GAL 
but also the N-terminal fragments like GAL(1-15) are active in the Central 
Nervous System [2, 3]. Recently, we described that GAL(1-15) induces strong 
depression-related and anxiogenic-like effects in rats, and these effects were 
significantly stronger than the ones induced by GAL [4]. The GALR1-GALR2 
heteroreceptor complexes in the dorsal hippocampus and especially in the 
dorsal raphe (DR), areas rich in GAL(1-15) binding sites [5] were involved in 
these effects [4, 6] and demonstrated also in cellular models.  
In the present study, we have analyzed the ability of GAL(1-15) to modulate 5-
HT1AR located at postjunctional sites and at the soma-dendritic level in rats. 
We have analyzed the effect of GAL(1-15) on the 5-HT1AR-mediated response 
in a behavioral test of depression and the involvement of the GALR2 in these 
effects. GAL(1-15) enhanced the antidepressant effects induced by the 5-
HT1AR agonist 8-OH-DPAT in the forced swimming test [7]. These effects were 
stronger than the ones induced by GAL. The mechanism of this action involved 
interactions at the receptor level in the plasma membrane with changes also at 
the transcriptional level. Thus, GAL(1-15) affected the binding characteristics as 
well as the mRNA level of 5-HT1AR in the dorsal hippocampus and DR. GALR2 
was involved in these effects, since the specific GALR2 antagonist M871 
blocked GAL(1-15) mediated actions at the behavioral and receptor level [7]. 
Furthermore, the results on the proximity ligation assay (PLA) in this work 
suggest the existence of GALR1-GALR2-5-HT1AR heteroreceptor complexes 
since positive PLA were obtained for both GALR1-5-HT1AR and GALR2-5-
HT1AR complexes in the DR and hippocampus. Moreover the studies on 
RN33B cells, where GALR1, GALR2 and 5-HT1AR exist [4], also showed PLA-
positive clusters indicating the existence of GALR1-5-HT1AR and GALR2-5-
HT1AR complexes in these cells [7]. 
In conclusion, our results indicate that GAL(1–15) enhances the antidepressant 
effects induced by the 5-HT1AR agonist 8-OH-DPAT probably acting on 
GALR1-GALR2-5-HT1AR heteroreceptor located at postjunctional sites and at 
the soma-dendritic level. The development of new drugs specifically targeting 
these heteroreceptor complexes may offer a novel strategy for treatment of 
depression. 
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